NCT05603624

Brief Summary

This prospective randomized controlled study examines whether the type of glove used (sterile vs clean) for cervical examination to assess progression in labor impacts the rates of intrapartum and/or postpartum infection in patients during labor or induction of labor at term.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
163

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2021

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 2, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 28, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 2, 2022

Completed
Last Updated

August 25, 2023

Status Verified

August 1, 2023

Enrollment Period

12 months

First QC Date

October 28, 2022

Last Update Submit

August 24, 2023

Conditions

Keywords

Sterile gloveClean gloveGlove typeIntraamniotic infectionCervical examinationSterile vaginal examinationIntrapartum infectionPostpartum infection

Outcome Measures

Primary Outcomes (1)

  • Chorioamnionitis or intraamniotic or intrauterine infection

    As defined by ACOG committee opinion 712

    Through study completion, usually withing 72 hours after admission to labor and delivery

Secondary Outcomes (1)

  • Postpartum endometritis

    Through study completion, usually withing 72 hours after admission to labor and delivery

Study Arms (2)

Sterile glove

ACTIVE COMPARATOR

Sterile glove is usually the standard of care

Procedure: Cervical examination to assess labor

Clean glove

EXPERIMENTAL

Clean glove is usually not used or in the event of an emergency or lack of access to sterile gloves in the United States.

Procedure: Cervical examination to assess labor

Interventions

Patients were randomized to receive cervical examinations to assess progression in labor with either sterile or clean gloves.

Clean gloveSterile glove

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Between 18 and 50 years old
  • Term pregnancy (37w0d to 41w6d gestational age)
  • Amniotic membranes were intact on admission
  • Patient presenting in spontaneous labor or were to undergo induction of labor
  • Patient attempting for a vaginal delivery initially, even if the final delivery method was by cesarean section

You may not qualify if:

  • Preterm pregnancy (before 37w0d gestational age)
  • Postdate pregnancy (after 41w6d gestational age)
  • Ruptured membranes or premature rupture of membranes on admission
  • Patient being evaluated for preterm labor
  • Patient has diagnosis of chorioamnionitis or any intrauterine infection
  • Patient has an extrauterine infection that would compromise the diagnosis of intrauterine infection (e.g., COVID, upper respiratory infections, urinary tract infections, cellulitis, appendicitis, etc.)
  • Patient experiencing an immunocompromised state (e.g., human immunodeficiency virus, congenital syndromes, transplant recipient, or immunosuppressant use)
  • Patient with uncertainty of their gestational age and/or no prenatal care
  • Patient with an intrauterine fetal demise
  • Patient requesting a termination of the pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eastern Virginia Medical School

Norfolk, Virginia, 23507, United States

Location

Related Publications (9)

  • Lamont RF, Sobel JD, Akins RA, Hassan SS, Chaiworapongsa T, Kusanovic JP, Romero R. The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG. 2011 Apr;118(5):533-49. doi: 10.1111/j.1471-0528.2010.02840.x. Epub 2011 Jan 20.

  • Larsen B, Monif GR. Understanding the bacterial flora of the female genital tract. Clin Infect Dis. 2001 Feb 15;32(4):e69-77. doi: 10.1086/318710. Epub 2001 Feb 9.

  • Perez-Munoz ME, Arrieta MC, Ramer-Tait AE, Walter J. A critical assessment of the "sterile womb" and "in utero colonization" hypotheses: implications for research on the pioneer infant microbiome. Microbiome. 2017 Apr 28;5(1):48. doi: 10.1186/s40168-017-0268-4.

  • Committee Opinion No. 712: Intrapartum Management of Intraamniotic Infection. Obstet Gynecol. 2017 Aug;130(2):e95-e101. doi: 10.1097/AOG.0000000000002236.

  • Rouse DJ, Landon M, Leveno KJ, Leindecker S, Varner MW, Caritis SN, O'Sullivan MJ, Wapner RJ, Meis PJ, Miodovnik M, Sorokin Y, Moawad AH, Mabie W, Conway D, Gabbe SG, Spong CY; National Institute of Child Health And Human Development, Maternal-Fetal Medicine Units Network. The Maternal-Fetal Medicine Units cesarean registry: chorioamnionitis at term and its duration-relationship to outcomes. Am J Obstet Gynecol. 2004 Jul;191(1):211-6. doi: 10.1016/j.ajog.2004.03.003.

  • Sweeney EL, Dando SJ, Kallapur SG, Knox CL. The Human Ureaplasma Species as Causative Agents of Chorioamnionitis. Clin Microbiol Rev. 2016 Dec 14;30(1):349-379. doi: 10.1128/CMR.00091-16. Print 2017 Jan.

  • Cahill AG, Duffy CR, Odibo AO, Roehl KA, Zhao Q, Macones GA. Number of cervical examinations and risk of intrapartum maternal fever. Obstet Gynecol. 2012 Jun;119(6):1096-101. doi: 10.1097/AOG.0b013e318256ce3f.

  • Gluck O, Mizrachi Y, Ganer Herman H, Bar J, Kovo M, Weiner E. The correlation between the number of vaginal examinations during active labor and febrile morbidity, a retrospective cohort study. BMC Pregnancy Childbirth. 2020 Apr 25;20(1):246. doi: 10.1186/s12884-020-02925-9.

  • Morshedi B, Strohm S, James H, Springer C, Gould L, Thurman A, Slat S. Effect of sterile vs clean gloves for cervical checks in labor on maternal infection at term: a randomized trial. Am J Obstet Gynecol MFM. 2023 Jun;5(6):100931. doi: 10.1016/j.ajogmf.2023.100931. Epub 2023 Mar 24.

MeSH Terms

Conditions

ChorioamnionitisPuerperal Infection

Condition Hierarchy (Ancestors)

Fetal DiseasesPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesFetal Membranes, Premature RuptureObstetric Labor ComplicationsPlacenta DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesPregnancy Complications, InfectiousInfectionsPuerperal Disorders

Study Officials

  • Stacy Slat, MD

    Eastern Virginia Medical School

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The two types of gloves used were labeled as "Glove 1" and "Glove 2" for data collection and analysis. The providers performing examinations and the patients knew the type of glove being used at the time of the study but data collection was deidentified and retrospective analysis was blinded to the investigating team until the study concluded.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Eligible and consented participants were randomized to receive all cervical examinations with sterile powder-free polyvinyl chloride exam gloves (current routine practice, control group) or clean powder-free nitrile exam gloves (nonsterile, experimental group). Neither the clinical providers performing the exam nor the participants were blinded to the glove type used, however, the researchers did not know which glove type was used while completing the retrospective data collection and analysis. All other obstetrical care provided to the participants was per ACOG guidelines and the only changes made to their care was the type of glove used for this study.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 28, 2022

First Posted

November 2, 2022

Study Start

September 2, 2021

Primary Completion

September 1, 2022

Study Completion

September 1, 2022

Last Updated

August 25, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will share

If contacted, can share deidentified participant data.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
After analysis and upon request; for undetermined amount of time.
Access Criteria
If contacted, can share deidentified participant data.

Locations